<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03943823</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-15-0337</org_study_id>
    <nct_id>NCT03943823</nct_id>
  </id_info>
  <brief_title>Postmenopausal Pessary Users: Estrogen Versus Trimosan</brief_title>
  <official_title>Postmenopausal Pessary Users: Estrogen Versus Trimosan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare vaginally applied estrogen with the vaginal gel
      trimosan for their effects on vaginal pH and vaginal symptoms in postmenopausal pessary
      users.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 7, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal pH as measured by pH strips</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Vaginal pH as measured by pH strips</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vaginal Symptoms as assessed by a vaginitis questionnaire</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vaginal Symptoms as assessed by a vaginitis questionnaire</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with vaginosis infection</measure>
    <time_frame>baseline</time_frame>
    <description>Vaginosis infection will be diagnosed either by gram staining or an Affirm bacterial vaginosis (BV) test, which probes for DNA of microorganisms that cause BV.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with vaginosis infection</measure>
    <time_frame>3 months</time_frame>
    <description>Vaginosis infection will be diagnosed either by gram staining or by an Affirm bacterial vaginosis (BV) test, which probes for DNA of microorganisms that cause BV.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Vaginosis</condition>
  <condition>Vaginosis, Bacterial</condition>
  <condition>Vaginal Discharge</condition>
  <arm_group>
    <arm_group_label>Estrogen vaginal cream</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Trimo-San vaginal gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Estrogen vaginal cream</intervention_name>
    <description>Either Premarin or Estrace cream will be used (dependent on patient's insurance). Premarin 1 gram every night for the first 7 days, then 0.5 grams twice weekly. Estrace cream 2 grams daily for first 7 days, then 1 gram twice-weekly.</description>
    <arm_group_label>Estrogen vaginal cream</arm_group_label>
    <other_name>Estrace Cream</other_name>
    <other_name>Premarin Cream</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Trimo-San vaginal gel</intervention_name>
    <description>Half applicator for three times a week for 1st week, then half applicator for 2 times a week.</description>
    <arm_group_label>Trimo-San vaginal gel</arm_group_label>
    <other_name>Trimo-San</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Postmenopausal female pessary user (ring with support pessaries only). Postmenopausal
             will be defined as: amenorrhea for a year or 3 months after surgical bilateral
             salpingo-oophorectomy

          -  Is a new pessary user, or has not had a pessary for a year

        Exclusion Criteria:

          -  Pregnancy

          -  Persistent Bacterial Vaginosis infection in the first two clinic encounters

          -  Currently on hormone replacement therapy

          -  Previously on hormone replacement therapy in the past 6 months

          -  Currently on antibiotics

          -  Patients with existing vaginal erosions/ulcerations
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gazala Siddiqui, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Konny Fong</last_name>
    <phone>713-500-6574</phone>
    <email>Konny.ChanFong@uth.tmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Konny Fong</last_name>
      <phone>713-500-6574</phone>
      <email>Konny.ChanFong@uth.tmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 7, 2019</study_first_submitted>
  <study_first_submitted_qc>May 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2019</study_first_posted>
  <last_update_submitted>May 7, 2019</last_update_submitted>
  <last_update_submitted_qc>May 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Gazala Siddiqui</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Pessary</keyword>
  <keyword>Vaginal pH</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginosis, Bacterial</mesh_term>
    <mesh_term>Vaginal Diseases</mesh_term>
    <mesh_term>Vaginal Discharge</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Estrogens</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

